Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: RANBAXY PHARMACEUTICALS (PTY) LTD, 14 Lautre Road, Stormill, Ext.1, Roodepoort, 1724, South Africa
BETAPAM Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Yellow, biconvex, scored tablets. |
Each tablet contains 5 mg diazepam.
Contains sugar (lactose monohydrate): 145,7 mg per tablet.
Contains Tartrazine.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diazepam |
Diazepam is a psychotropic substance from the class of 1,4-benzodiazepines with marked properties of suppression of tension, agitation and anxiety as well as sedative and hypnotic effects. In addition, diazepam demonstrates muscle relaxant and anticonvulsive properties. It is used in the short-term treatment of anxiety and tension states, as a sedative and premedicant, in the control of muscle spasm and in the management of alcohol withdrawal symptoms. |
| List of Excipients |
|---|
|
Certolake Tartrazine (C.I. 19140) |
Amber PVC containers of 30,100, 500, and 1000 tablets.
Polypropylene containers of 100 and 500 tablets.
H.D.P.E. Bucket of 5000 tablets.
Patient ready packs of different pack sizes.
RANBAXY PHARMACEUTICALS (PTY) LTD, 14 Lautre Road, Stormill, Ext.1, Roodepoort, 1724, South Africa
L/2.6/185 (S.A)
18 April 1979
| Drug | Countries | |
|---|---|---|
| BETAPAM | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
